"Designing Growth Strategies is in our DNA"

Cancer Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Preventive and Therapeutic), By Indication (Cervical Cancer, Prostate Cancer, Bladder Cancer, and Lung Cancer), By Distribution Channel (Hospitals, Government Suppliers, and Others), and Regional Forecasts, 2022-2029

Region : Global | Format: PDF | Report ID: FBI106958

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Cancer, Key Countries/ Region, 2021
    2. Overview of Regulatory Scenario by Key Countries
    3. Pipeline Analysis, Key Players
    4. Key Industry Developments, Mergers, Acquisitions, Product Launches, etc.
    5. Impact of COVID-19 on Global Cancer Vaccines Market
  5. Global Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Preventive
      2. Therapeutic
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cervical Cancer
      2. Prostate Cancer
      3. Bladder Cancer
      4. Lung Cancer
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Preventive
      2. Therapeutic
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cervical Cancer
      2. Prostate Cancer
      3. Bladder Cancer
      4. Lung Cancer
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Preventive
      2. Therapeutic
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cervical Cancer
      2. Prostate Cancer
      3. Bladder Cancer
      4. Lung Cancer
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. France
      2. Italy
      3. Spain
      4. UK
      5. Germany
      6. Rest of Europe
  8. Asia Pacific Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Preventive
      2. Therapeutic
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cervical Cancer
      2. Prostate Cancer
      3. Bladder Cancer
      4. Lung Cancer
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Government Suppliers
      3. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. India
      2. China
      3. Australia
      4. Japan
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Rest of the World Cancer Vaccines Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Type
      1. Preventive
      2. Therapeutic
    2. Market Analysis, Insights and Forecast – By Indication
      1. Cervical Cancer
      2. Prostate Cancer
      3. Bladder Cancer
      4. Lung Cancer
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals
      2. Government Suppliers
      3. Others
  10. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Dendreon Pharmaceuticals LLC.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Serum Institute of India Pvt. Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Merck & Co., Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. GSK plc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Walvax Biotechnology Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Biomed Lublin S.A.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Center of Molecular Immunology
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Xiamen Innovax Biotech Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Wantai BioPharm
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Organon Teknika Corp., LLC
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 01: Global Cancer Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2021 & 2029

Figure 02: Global Cancer Vaccines Market Value Share (%), By Type, 2021 & 2029

Figure 03: Global Cancer Vaccines Market Value Share (%), By Indication, 2021 & 2029

Figure 04: Global Cancer Vaccines Market Value Share (%), By Distribution Channel, 2021 & 2029

Figure 05: Global Cancer Vaccines Market Value Share (%), By Region, 2021 & 2029

Figure 06: North America Cancer Vaccines Market Value (USD billion), by Type, 2021 & 2029

Figure 07: North America Cancer Vaccines Market Value Share (%), by Type, 2021

Figure 08: North America Cancer Vaccines Market Value (USD billion), by Indication, 2021 & 2029

Figure 09: North America Cancer Vaccines Market Value Share (%), by Indication, 2021

Figure 10: North America Cancer Vaccines Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 11: North America Cancer Vaccines Market Value Share (%), by Distribution Channel, 2021

Figure 12: North America Cancer Vaccines Market Value (USD billion), by Country, 2021 & 2029

Figure 13: North America Cancer Vaccines Market Value Share (%), by Country, 2021

Figure 14: Europe Cancer Vaccines Market Value (USD billion), by Type, 2021 & 2029

Figure 15: Europe Cancer Vaccines Market Value Share (%), by Type, 2021

Figure 16: Europe Cancer Vaccines Market Value (USD billion), by Indication, 2021 & 2029

Figure 17: Europe Cancer Vaccines Market Value Share (%), by Indication, 2021

Figure 18: Europe Cancer Vaccines Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 19: Europe Cancer Vaccines Market Value Share (%), by Distribution Channel, 2021

Figure 20: Europe Cancer Vaccines Market Value (USD billion), by Country, 2021 & 2029

Figure 21: Europe Cancer Vaccines Market Value Share (%), by Country, 2021

Figure 22: Asia Pacific Cancer Vaccines Market Value (USD billion), by Type, 2021 & 2029

Figure 23: Asia Pacific Cancer Vaccines Market Value Share (%), by Type, 2021

Figure 24: Asia Pacific Cancer Vaccines Market Value (USD billion), by Indication, 2021 & 2029

Figure 25: Asia Pacific Cancer Vaccines Market Value Share (%), by Indication, 2021

Figure 26: Asia Pacific Cancer Vaccines Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 27: Asia Pacific Cancer Vaccines Market Value Share (%), by Distribution Channel, 2021

Figure 28: Asia Pacific Cancer Vaccines Market Value (USD billion), by Country, 2021 & 2029

Figure 29: Asia Pacific Cancer Vaccines Market Value Share (%), by Country, 2021

Figure 30: Rest of the World Cancer Vaccines Market Value (USD billion), by Type, 2021 & 2029

Figure 31: Rest of the World Cancer Vaccines Market Value Share (%), by Type, 2021

Figure 32: Rest of the World Cancer Vaccines Market Value (USD billion), by Indication, 2021 & 2029

Figure 33: Rest of the World Cancer Vaccines Market Value Share (%), by Indication, 2021

Figure 34: Rest of the World Cancer Vaccines Market Value (USD billion), by Distribution Channel, 2021 & 2029

Figure 35: Rest of the World Cancer Vaccines Market Value Share (%), by Distribution Channel, 2021

Figure 36: Global Cancer Vaccines Market Share Analysis (%), By Company, 2021

Table 01: Global Cancer Vaccines Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 02: Global Cancer Vaccines Market Revenue (USD billion) Forecast, By Indication, 2018–2029

Table 03: Global Cancer Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 04: Global Cancer Vaccines Market Revenue (USD billion) Forecast, By Region, 2018–2029

Table 05: North America Cancer Vaccines Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 06: North America Cancer Vaccines Market Revenue (USD billion) Forecast, By Indication, 2018–2029

Table 07: North America Cancer Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 08: North America Cancer Vaccines Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 09: Europe Cancer Vaccines Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 10: Europe Cancer Vaccines Market Revenue (USD billion) Forecast, By Indication, 2018–2029

Table 11: Europe Cancer Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 12: Europe Cancer Vaccines Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 13: Asia Pacific Cancer Vaccines Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 14: Asia Pacific Cancer Vaccines Market Revenue (USD billion) Forecast, By Indication, 2018–2029

Table 15: Asia Pacific Cancer Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

Table 16: Asia Pacific Cancer Vaccines Market Revenue (USD billion) Forecast, By Country, 2018–2029

Table 17: Rest of the World Cancer Vaccines Market Revenue (USD billion) Forecast, By Type, 2018–2029

Table 18: Rest of the World Cancer Vaccines Market Revenue (USD billion) Forecast, By Indication, 2018–2029

Table 19: Rest of the World Cancer Vaccines Market Revenue (USD billion) Forecast, By Distribution Channel, 2018–2029

  • Nov, 2022
  • 2021
  • 2018-2020
  • 136

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X